YPHDFYpsomed Holding AG

About Ypsomed Holding AG (YPHDF)

Ypsomed Holding AG (YPHDF) is a Medical Instruments & Supplies company headquartered in Burgdorf, Switzerland whose shares trade over-the-counter on the Pink tier.

The Ypsomed Group is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands mylife Diabetescare directly to patients or through pharmacies and clinics and under YDS Ypsomed Delivery Systems business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs almost 1 700 employees.

YPHDF key facts

Ticker symbol

YPHDF

Market tier

Pink

Sector

Healthcare

Industry

Medical Instruments & Supplies

Headquarters

Burgdorf, Switzerland

Estimated market cap

$5.27B (as of May 14, 2025)

Shares outstanding

12,602,953

Reporting standard

International Reporting: SIX Swiss Exchange

Audit status

Not Available

Fiscal year end

3/31

Explore more: Medical Instruments & Supplies stocks · Healthcare sector · Pink stocks · OTC stocks starting with Y